Addressing Racism and Disparities during Therapeutic Development and in the Clinic

With the spread of a pandemic that disproportionately affects communities of color and continued systemic inequality, BIO has launched the BIOEquality Agenda with a primary goal of promoting health equity. Learn from biopharma executives, clinicians, and patient advocates about pathways to ensure that clinical trials are representative of patient populations and companies ensure access to prevention and treatment of diseases including COVID-19.